NNIT to support COVID-19 vaccine safety data capture

NNIT, a trusted partner of AstraZeneca’s since 2014, will be implementing the critical COVID-19 vaccine post-marketing safety data system.

NNIT is supporting AstraZeneca and leveraging its expertise in global pharmacovigilance systems to meet the challenges of patient safety during the ongoing global pandemic.

NNIT’s leadership of this global, federated project includes coordination and holistic management of the AstraZeneca vaccine efforts as well as tracking and oversight of the COVID-19 vaccine’s pharmacovigilance post-marketing events.

The partnership is focused on rapid scaling of global capabilities.

NNIT’s implementation team has been working closely with AstraZeneca since June 2020 to design and execute the project at an unprecedented pace to meet the expectations of vaccine delivery.

Rasmus Koch Nelund, Corporate Vice President, Life Sciences, NNIT, elaborates on the partnership:

“NNIT is providing end-to-end implementation and support services within a proven framework delivered by a dedicated team of drug safety systems experts. To meet the project’s critical timelines while maintaining accuracy and compliance with regulatory bodies, our team is conducting a parallel workstream approach. We’re very pleased that we can lend our expertise to this project and play our part in battling the ongoing pandemic. We share the sense of urgency with the world and have the very best people positioned to support AstraZeneca in their efforts to bring a vaccine to the world’s population as quickly and safely as possible.”